Search Results
483 results found for "Cost-efficient medications https://simplemedrx.top"
- Anavex Comments on New Alzheimer’s Disease Diagnostic Guidelines
Angelos Stergiou, Vice President of Clinical Development & Medical Affairs for Anavex. criteria and guidelines for Alzheimer’s disease is available on the Alzheimer’s Association web site: http About Alzheimer’s Disease While Alzheimer’s disease is most common in people over the age of 65, it can Research & Business Development Email: info@anavex.com Shareholder & Media Relations Toll-free: 1-866
- Anavex Appoints Robert Chisholm to Board of Directors
Chisholm served as CFO for PNI Digital Media (formerly PhotoChannel Networks Inc.) between September The company thanks for him for his dedicated service to the company and wishes him well in his future Research & Business Development Email: info@anavex.com Shareholder & Media Relations Toll-free: 1-866
- Anavex First-in-Human Dosing Commenced in ANAVEX 2-73 Clinical Trial for Alzheimer's Disease
dosed with the study drug, according to the study protocol, and no adverse events have been recorded post Ozkan Yalkinoglou, Medical Director of ABX-CRO. Its first-in-human administration is the most significant and important milestone in our corporate history Angelos Stergiou, Vice President of Clinical Development & Medical Affairs for Anavex. About Alzheimer’s Disease While Alzheimer’s disease is most common in people over the age of 65, it can
- Anavex Appoints Dr. Christopher Shackleton as an Advisor
He holds triple specialist credentials in medical and surgical disciplines, and has a track record of In addition to obtaining his medical education and training from the University of British Columbia, University of Toronto and Harvard Medical School, Dr. His medical credentials and financial acumen make him well qualified to provide us with strategic advice Its impact on individuals and their loved ones is devastating while the societal and economic costs are
- Anavex to Hold Annual Meeting on April 11, 2011
Research & Business Development Email: info@anavex.com Shareholder & Media Relations Toll-free: 1-866
- Anavex Screening Healthy Volunteers for Phase I, First-in-Human Clinical Study in AD
About Alzheimer’s Disease While Alzheimer’s disease is most common in people over the age of 65, it can Research & Business Development Email: info@anavex.com Shareholder & Media Relations Toll-free: 1-866
- Anavex Management to Hold Live Investor Conference Call Today at 4:30PM ET
(“Anavex”) (OTCBB: AVXL) will host a live conference call today at 4:30pm ET. A recorded version of the call will be posted on our web site shortly after the call. About Alzheimer’s Disease While Alzheimer’s disease is most common in people over the age of 65, it can Research & Business Development Email: info@anavex.com Shareholder & Media Relations Toll-free: 1-866
- Anavex Receives Approval to Commence Phase I Clinical Trial in Alzheimer’s Disease
Angelos Stergiou, Anavex’s Vice President, Clinical Development & Medical Affairs. Conference Call Management will host a live investor conference call on Wednesday, March 16, 2011 at A recorded version of the call will be posted on our web site shortly after the call. About Alzheimer’s Disease While Alzheimer’s disease is most common in people over the age of 65, it can Research & Business Development Email: info@anavex.com Shareholder & Media Relations Toll-free: 1-866
- Anavex Appoints Dr. Jeffrey Cummings to its Scientific Advisory Board
About Alzheimer’s Disease While Alzheimer’s disease is most common in people over the age of 65, it can Research & Business Development Email: info@anavex.com Shareholder & Media Relations Toll-free: 1-866
- Anavex Appoints Independent Director
Research & Business Development Email: info@anavex.com Shareholder & Media Relations Toll-free: 1-866
- Anavex Appoints Dr. Rachelle Doody to Scientific Advisory Board
available, FDA-approved drugs for Alzheimer’s disease, and was the lead site for the development of the most About Alzheimer’s Disease While Alzheimer’s disease is most common in people over the age of 65, it can Research & Business Development Email: info@anavex.com Shareholder & Media Relations Toll-free: 1-866
- Anavex Adds Dr. Paul Aisen to Scientific Advisory Board
About Alzheimer’s While Alzheimer’s is most common in people over the age of 65, it can strike adults Research & Business Development Email: info@anavex.com Shareholder & Media Relations Toll-free: 1-866
